• LAST PRICE
    10.2900
  • TODAY'S CHANGE (%)
    Trending Up0.4400 (4.4670%)
  • Bid / Lots
    7.0000/ 18
  • Ask / Lots
    12.0000/ 1
  • Open / Previous Close
    9.9400 / 9.8500
  • Day Range
    Low 9.8600
    High 10.3600
  • 52 Week Range
    Low 6.0950
    High 34.3600
  • Volume
    129,890
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 9.85
TimeVolumePHAT
09:32 ET96910.12
09:34 ET40010
09:36 ET1009.86
09:38 ET5009.8731
09:45 ET113610.0415
09:48 ET10010
10:01 ET20010.13
10:03 ET11210.075
10:12 ET43010.12
10:17 ET5009.93
10:24 ET5009.99
10:26 ET180010.19
10:30 ET20010.33
10:32 ET40010.28
10:35 ET29510.3
10:39 ET85410.25
10:44 ET10010.22
10:48 ET10010.21
10:53 ET89610.18
10:55 ET40010.131
10:57 ET10010.13
11:00 ET30010.13
11:02 ET10010.06
11:06 ET70010.086
11:09 ET30010.09
11:13 ET10010.08
11:15 ET20010.07
11:18 ET20010.15
11:20 ET40010.18
11:22 ET20010.18
11:26 ET40010.18
11:27 ET70010.11
11:31 ET48910.1
11:33 ET20010.1
11:36 ET30010.11
11:40 ET10010.11
11:42 ET110010.08
11:44 ET30010.08
11:49 ET60010.13
11:51 ET10010.19
11:58 ET10010.16
12:00 ET60010.17
12:05 ET10010.14
12:12 ET30010.13
12:14 ET10010.1575
12:16 ET50010.15
12:18 ET30010.09
12:21 ET80010.1
12:25 ET20010.07
12:30 ET401710.04
12:32 ET83310.0575
12:34 ET30010.03
12:39 ET28310.04
12:43 ET1009.99
12:45 ET10010.01
12:48 ET20010.05
12:50 ET60010.05
12:56 ET70010.05
12:59 ET66210.07
01:01 ET19510.12
01:06 ET20010.15
01:19 ET49310.2
01:26 ET10010.19
01:28 ET50010.165
01:30 ET40410.12
01:33 ET10010.1
01:35 ET80010.16
01:39 ET60010.125
01:46 ET68310.09
01:48 ET40010.12
01:50 ET10010.1
01:51 ET20010.09
02:04 ET50010
02:08 ET10010.06
02:11 ET73710.08
02:13 ET50010.07
02:20 ET10010.05
02:22 ET10010.07
02:27 ET20010.07
02:29 ET10010.07
02:33 ET20010.08
02:36 ET20010.085
02:40 ET50010.085
02:42 ET40010.065
02:45 ET30010.07
02:49 ET50010.04
02:51 ET30010.09
02:54 ET40010.11
02:56 ET10010.11
02:58 ET10010.08
03:02 ET10010.07
03:03 ET40010.11
03:12 ET20010.15
03:16 ET10010.15
03:20 ET30010.16
03:21 ET151610.14
03:23 ET52010.185
03:25 ET33210.1818
03:27 ET80010.18
03:34 ET30010.19
03:36 ET20010.15
03:38 ET10010.17
03:39 ET50010.15
03:41 ET100010.2
03:43 ET20010.19
03:45 ET40010.21
03:48 ET110010.195
03:50 ET160010.25
03:52 ET160010.26
03:54 ET286210.26
03:56 ET170010.32
03:57 ET152810.33
03:59 ET812610.29
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPHAT
Phathom Pharmaceuticals Inc
383.9M
-2.2x
---
United StatesRGC
Regencell Bioscience Holdings Ltd
424.1M
-89.2x
---
United StatesCYDY
Cytodyn Inc
382.9M
-1.9x
---
United StatesTCRT
Alaunos Therapeutics Inc
464.8M
-8.1x
---
United StatesMLTX
MoonLake Immunotherapeutics
387.4M
-5.9x
---
United StatesOCGN
Ocugen Inc
379.0M
-6.7x
---
As of 2022-09-28

Company Information

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company, which is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. The Company’s pipeline product candidate, vonoprazan is an oral small molecule potassium-competitive acid blocker (P-CAB). P-CABs are a class of medicines that block acid secretion in the stomach. Vonoprazan has an anti-secretory effect and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease (GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.

Contact Information

Headquarters
100 CAMPUS DRIVE,, SUITE 102FLORHAM PARK, NJ, United States 07932
Phone
302-636-5400
Fax
302-636-5454

Executives

Director
Terrie Curran
Co-Founder, Chief Operating Officer
Azmi Nabulsi
Co-Founder, Director
David Socks
Chief Financial Officer
Molly Henderson
Independent Director
Michael Cola

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$383.9M
Revenue (TTM)
$0.00
Shares Outstanding
39.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-4.74
Book Value
$2.36
P/E Ratio
-2.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.